<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39689011</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1572-0241</ISSN><JournalIssue CitedMedium="Internet"><Volume>120</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>17</Day></PubDate></JournalIssue><Title>The American journal of gastroenterology</Title><ISOAbbreviation>Am J Gastroenterol</ISOAbbreviation></Journal><ArticleTitle>Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Constipation-Predominant Irritable Bowel Syndrome: A Single-Center, Single-Blind, Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>2139</StartPage><EndPage>2153</EndPage><MedlinePgn>2139-2153</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.14309/ajg.0000000000003257</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Transcutaneous auricular vagus nerve stimulation (taVNS) is a promising therapy for irritable bowel syndrome (IBS). The aims of this clinical trial were to evaluate the influence of taVNS on autonomic functions, rectal sensation, and acetylcholine (Ach) levels and to explore potential mechanisms involving gut microbiota and metabolic profiles.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study was a single-center, single-blind, randomized controlled trial executed at the First Affiliated Hospital of USTC, Anhui, China. Individual patients' constipation-predominant IBS (IBS-C)-related symptoms and mental health were assessed and scored using questionnaires at baseline and at week 4. Levels of serum Ach and nitric oxide, anorectal manometry, and heart rate variability were assessed both before and after the therapy. Fecal samples from each group were assessed to compare the gut microbiota, short-chain fatty acids, and gut microbiota-derived tryptophan metabolites.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Between September 2023 and May 2024, 40 patients (n = 20 in both taVNS and sham-taVNS groups) completed the 4-week study by performing an intention-to-treat analysis. No differences in all parameters between taVNS and sham-taVNS groups at the baseline were found. The taVNS significantly improved the visual analog scale score ( P &lt; 0.001), IBS Severity Scoring System score ( P &lt; 0.001), weekly frequency of spontaneous bowel movements ( P &lt; 0.001), weekly frequency of complete spontaneous bowel movements ( P = 0.004), Bristol Stool Form Scale score ( P &lt; 0.001), Hamilton Anxiety Scale score ( P &lt; 0.001), Hamilton Depression Scale score ( P &lt; 0.001), and IBS Quality of Life score ( P &lt; 0.001). Furthermore, taVNS improved rectal sensation in patients with IBS-C, including improvements in the threshold volume for initial sensation ( P = 0.033), urge to defecate ( P = 0.022), and rectoanal inhibitory reflex ( P = 0.002). Moreover, taVNS elevated serum levels of Ach ( P = 0.005) and reduced nitric oxide ( P = 0.016) while also enhancing vagal activity ( P &lt; 0.001) as determined by spectral analysis of heart rate variability. Three patients in the taVNS group and 2 in the control group had adverse consequences, which were manageable. In addition, taVNS led to a significant rise in the level of the genus Bifidobacterium ( P = 0.038) and increased levels of acetic ( P = 0.003), butyric ( P = 0.011), and propionic ( P = 0.005) acids. It also decreased tryptophan metabolism content, including 3-hydroxyanthranilic acid ( P = 0.007), anthranilic acid ( P = 0.026), and L-tryptophan ( P = 0.002).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The study manifested that noninvasive taVNS effectively improved constipation and abdominal pain symptoms in patients with IBS-C. The alleviation of IBS-C symptoms may be attributed to the integrative effects of taVNS on rectal functions, mediated through vagal, cholinergic, and multiomics mechanisms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Chaolan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Mengqing</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Affiliated Provincial Hospital, Anhui Medical University, Hefei, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Mengtao</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0001-3381-8859</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Graduate School of Bengbu Medical University, Bengbu, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Graduate School of Bengbu Medical University, Bengbu, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Jiashuang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Affiliated Provincial Hospital, Anhui Medical University, Hefei, Anhui Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Kenji</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-8892-0439</Identifier><AffiliationInfo><Affiliation>Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology, Affiliated Provincial Hospital, Anhui Medical University, Hefei, Anhui Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No. 31870993</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>No. 1604b0602021</GrantID><Agency>External Science and Technology Cooperation Planning Projects of Anhui Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Gastroenterol</MedlineTA><NlmUniqueID>0421030</NlmUniqueID><ISSNLinking>0002-9270</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043183" MajorTopicYN="Y">Irritable Bowel Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003248" MajorTopicYN="Y">Constipation</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055536" MajorTopicYN="Y">Vagus Nerve Stimulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004561" MajorTopicYN="Y">Transcutaneous Electric Nerve Stimulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008365" MajorTopicYN="N">Manometry</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical trial</Keyword><Keyword MajorTopicYN="N">constipation</Keyword><Keyword MajorTopicYN="N">irritable bowel syndrome</Keyword><Keyword MajorTopicYN="N">transcutaneous auricular vagus nerve stimulation</Keyword></KeywordList><CoiStatement><b>Guarantor of the article:</b> Yue Yu, MD, PhD. <b>Specific author contributions:</b> Y.Y. and K.H.: designed the study. Y.Y.: received funding for the study. J.L., C.L., M.Y., M.Z., B.W., and J.T.: carried out the study. Y.Y. and J.L.: administered the project. J.L. and C.L.: analyzed the data. Y.Y.: verified the data. J.L. and K.H.: drafted the manuscript. All authors provided a critical review and approved the final manuscript. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication. <b>Financial support:</b> This study was funded by the National Natural Science Foundation of China grant (31870993) and External Science and Technology Cooperation Planning Projects of Anhui Province (1604b0602021). We thank all the participants for consenting to participate in our study. <b>Potential competing interests:</b> None to report. <b>Trial registration:</b>
http://www.chictr.org.cn (ChiCTR2400085832). <b>Data transparency statement:</b> The data for this study are available to other researchers for scientific research purposes on request and after the proposed analysis plan has been approved. For data access, please contact the corresponding author. The raw sequence data have been deposited in the SRA database under accession number PRJNA1108941.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>4</Day><Hour>0</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>17</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>17</Day><Hour>13</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39689011</ArticleId><ArticleId IdType="pmc">PMC12398348</ArticleId><ArticleId IdType="doi">10.14309/ajg.0000000000003257</ArticleId><ArticleId IdType="pii">00000434-990000000-01490</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: A clinical review. JAMA 2015;313(9):949&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">25734736</ArticleId></ArticleIdList></Reference><Reference><Citation>Khasawneh M, Shaikh FA, Ng CE, et al. Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden. Neurogastroenterol Motil 2024;36(4):e14756.</Citation><ArticleIdList><ArticleId IdType="pubmed">38321517</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeoka A, Kimura T, Hara S, et al. Prevalence of irritable bowel syndrome in Japan, China, and South Korea: An international cross-sectional study. J Neurogastroenterol Motil 2023;29(2):229&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10083109</ArticleId><ArticleId IdType="pubmed">37019867</ArticleId></ArticleIdList></Reference><Reference><Citation>Almario CV, Sharabi E, Chey WD, et al. Prevalence and burden of illness of Rome IV irritable bowel syndrome in the United States: Results from a nationwide cross-sectional study. Gastroenterology 2023;165(6):1475&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">37595647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballou S, McMahon C, Lee HN, et al. Effects of irritable bowel syndrome on daily activities vary among subtypes based on results from the IBS in America survey. Clin Gastroenterol Hepatol 2019;17(12):2471&#x2013;8.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675784</ArticleId><ArticleId IdType="pubmed">31419572</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilleri M, Boeckxstaens G. Irritable bowel syndrome: Treatment based on pathophysiology and biomarkers. Gut 2023;72(3):590&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9990119</ArticleId><ArticleId IdType="pubmed">36307180</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KY, Wang FY, Lv M, et al. Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment. World J Gastroenterol 2023;29(26):4120&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10354571</ArticleId><ArticleId IdType="pubmed">37475846</ArticleId></ArticleIdList></Reference><Reference><Citation>Paine P. Review article: Current and future treatment approaches for pain in IBS. Aliment Pharmacol Ther 2021;54(Suppl 1):S75&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">34927753</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng LH, Fang JY, Dai N, et al. Efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation: Chinese sub-cohort analysis of a phase III, randomized, double-blind, placebo-controlled trial. J Dig Dis 2022;23(2):99&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9314117</ArticleId><ArticleId IdType="pubmed">35019221</ArticleId></ArticleIdList></Reference><Reference><Citation>Song G, Trujillo S, Fu Y, et al. Transcutaneous electrical stimulation for gastrointestinal motility disorders. Neurogastroenterol Motil 2023;35(11):e14618.</Citation><ArticleIdList><ArticleId IdType="pubmed">37288650</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Dai Q, Qu T, et al. Ameliorating effects of transcutaneous auricular vagus nerve stimulation on a mouse model of constipation-predominant irritable bowel syndrome. Neurobiol Dis 2024;193:106440.</Citation><ArticleIdList><ArticleId IdType="pubmed">38369213</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Liu J, Lv C, et al. Integrative effects of transcutaneous auricular vagus nerve stimulation on esophageal motility and pharyngeal symptoms via vagal mechanisms in patients with laryngopharyngeal reflux disease. Front Neurosci 2024;18:1287809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10954818</ArticleId><ArticleId IdType="pubmed">38516311</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaz B, Sinniger V, Pellissier S. Vagal tone: Effects on sensitivity, motility, and inflammation. Neurogastroenterol Motil 2016;28(4):455&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">27010234</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt MF, Albusoda A, Farmer AD, et al. The anatomical basis for transcutaneous auricular vagus nerve stimulation. J Anat 2020;236(4):588&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7083568</ArticleId><ArticleId IdType="pubmed">31742681</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvioli B, Pellegatta G, Malacarne M, et al. Autonomic nervous system dysregulation in irritable bowel syndrome. Neurogastroenterol Motil 2015;27(3):423&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">25581440</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X, Hu Y, Zhang B, et al. Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation. JCI Insight 2021;6(14):e150052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8410029</ArticleId><ArticleId IdType="pubmed">34138761</ArticleId></ArticleIdList></Reference><Reference><Citation>Khasawneh M, Craig OF, Gracie DJ, et al. A diagnosis of irritable bowel syndrome using Rome IV criteria and limited investigations is durable in secondary care. Clin Gastroenterol Hepatol 2023;21(13):3397&#x2013;404.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">37302448</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukasik J, Dierikx T, Besseling-van der Vaart I, et al. Multispecies probiotic for the prevention of antibiotic-associated diarrhea in children: A randomized clinical trial. JAMA Pediatr 2022;176(9):860&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214631</ArticleId><ArticleId IdType="pubmed">35727573</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Xu F, Sun C, et al. Noninvasive transcutaneous auricular vagal nerve stimulation improves gastric slow waves impaired by cold stress in healthy subjects. Neuromodulation 2023;26(8):1851&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">35597733</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou L, Rong P, Yang Y, et al. Auricular vagus nerve stimulation improves visceral hypersensitivity and gastric motility and depression-like behaviors via vago-vagal pathway in a rat model of functional dyspepsia. Brain Sci 2023;13(2):253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9954117</ArticleId><ArticleId IdType="pubmed">36831796</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Liu B, Wu Y, et al. Meniere disease treated with transcutaneous auricular vagus nerve stimulation combined with betahistine Mesylate: A randomized controlled trial. Brain Stimul 2023;16(6):1576&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">37838094</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilleri M, Lembo AJ, Lavins BJ, et al. Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-C. United European Gastroenterol J 2015;3(1):53&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4315678</ArticleId><ArticleId IdType="pubmed">25653859</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997;11(2):395&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">9146781</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson M, Ohlsson B, Ulander K. Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS). BMC Gastroenterol 2007;7:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868742</ArticleId><ArticleId IdType="pubmed">17475020</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lv C, Wu D, et al. Subjective taste and smell changes in conjunction with anxiety and depression are associated with symptoms in patients with functional constipation and irritable bowel syndrome. Gastroenterol Res Pract 2021;2021:5491188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8476287</ArticleId><ArticleId IdType="pubmed">34589124</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Shi L, Huang D, et al. Depression and structural factors are associated with symptoms in patients of irritable bowel syndrome with diarrhea. J Neurogastroenterol Motil 2020;26(4):505&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547200</ArticleId><ArticleId IdType="pubmed">32675388</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WW, Zhou FS, Bushnell DM, et al. Cultural adaptation and application of the IBS-QOL in China: A disease-specific quality-of-life questionnaire. Qual Life Res 2007;16(6):991&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17440830</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997;32(9):920&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">9299672</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lv C, Wang W, et al. Slow, deep breathing intervention improved symptoms and altered rectal sensitivity in patients with constipation-predominant irritable bowel syndrome. Front Neurosci 2022;16:1034547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9673479</ArticleId><ArticleId IdType="pubmed">36408402</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Wei R, Liu Z, et al. Ameliorating effects of transcutaneous electrical acustimulation combined with deep breathing training on refractory gastroesophageal reflux disease mediated via the autonomic pathway. Neuromodulation 2019;22(6):751&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6771489</ArticleId><ArticleId IdType="pubmed">31347247</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Zhu K, Hu P, et al. Needleless transcutaneous neuromodulation accelerates postoperative recovery mediated via autonomic and immuno-cytokine mechanisms in patients with cholecystolithiasis. Neuromodulation 2019;22(5):546&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">30277014</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Fang H, Hong N, et al. Gut microbiome and metabonomic profile predict early remission to anti-integrin therapy in patients with moderate to severe ulcerative colitis. Microbiol Spectr 2023;11(3):e0145723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10269848</ArticleId><ArticleId IdType="pubmed">37199618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S, Luo L, Bian X, et al. Pu-erh tea restored circadian rhythm disruption by regulating tryptophan metabolism. J Agric Food Chem 2022;70(18):5610&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">35475616</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong P, Liu J, Wang L, et al. Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder: A nonrandomized controlled pilot study. J Affect Disord 2016;195:172&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828906</ArticleId><ArticleId IdType="pubmed">26896810</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacic K, Hainsworth K, Sood M, et al. Neurostimulation for abdominal pain-related functional gastrointestinal disorders in adolescents: A randomised, double-blind, sham-controlled trial. Lancet Gastroenterol Hepatol 2017;2(10):727&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">28826627</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasaelap A, Sood MR, Li BUK, et al. Efficacy of auricular neurostimulation in adolescents with irritable bowel syndrome in a randomized, double-blind trial. Clin Gastroenterol Hepatol 2020;18(9):1987&#x2013;94.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">31622740</ArticleId></ArticleIdList></Reference><Reference><Citation>Travagli RA, Anselmi L. Vagal neurocircuitry and its influence on gastric motility. Nat Rev Gastroenterol Hepatol 2016;13(7):389&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5605144</ArticleId><ArticleId IdType="pubmed">27251213</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanahashi Y, Komori S, Matsuyama H, et al. Functions of muscarinic receptor subtypes in gastrointestinal smooth muscle: A review of studies with receptor-knockout mice. Int J Mol Sci 2021;22(2):926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831928</ArticleId><ArticleId IdType="pubmed">33477687</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrington AM, Peck CJ, Liu L, et al. Localization of muscarinic receptors M1R, M2R and M3R in the human colon. Neurogastroenterol Motil 2010;22(9):999&#x2013;e263.</Citation><ArticleIdList><ArticleId IdType="pubmed">20146726</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo T, Nakajima M, Teraoka H, et al. Muscarinic receptor subtypes involved in regulation of colonic motility in mice: Functional studies using muscarinic receptor-deficient mice. Eur J Pharmacol 2011;670(1):236&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">21924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C, Wang KY, Gong MR, et al. Electro-acupuncture at ST37 and ST25 induce different effects on colonic motility via the enteric nervous system by affecting excitatory and inhibitory neurons. Neurogastroenterol Motil 2018;30(7):e13318.</Citation><ArticleIdList><ArticleId IdType="pubmed">29488287</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Lin Z, Lin C, et al. Transcutaneous electrical acustimulation improves irritable bowel syndrome with constipation by accelerating colon transit and reducing rectal sensation using autonomic mechanisms. Am J Gastroenterol 2022;117(9):1491&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">35973183</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J, Chen JD. Noninvasive electrical neuromodulation for gastrointestinal motility disorders. Expert Rev Gastroenterol Hepatol 2023;17(12):1221&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10842705</ArticleId><ArticleId IdType="pubmed">38018087</ArticleId></ArticleIdList></Reference><Reference><Citation>Clancy JA, Mary DA, Witte KK, et al. Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity. Brain Stimul 2014;7(6):871&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25164906</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xf8;kjaer JB, Bergmann S, Brock C, et al. Modulation of vagal tone enhances gastroduodenal motility and reduces somatic pain sensitivity. Neurogastroenterol Motil 2016;28(4):592&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26728182</ArticleId></ArticleIdList></Reference><Reference><Citation>Matteoli G, Boeckxstaens GE. The vagal innervation of the gut and immune homeostasis. Gut 2013;62(8):1214&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3711371</ArticleId><ArticleId IdType="pubmed">23023166</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller SJ, Teckentrup V, Rebollo I, et al. Vagus nerve stimulation increases stomach-brain coupling via a vagal afferent pathway. Brain Stimul 2022;15(5):1279&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">36067977</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajili&#x107;-Stojanovi&#x107; M, Biagi E, Heilig HG, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011;141(5):1792&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">21820992</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Qi Q, Wang Y, et al. Gut microbiota was modulated by moxibustion stimulation in rats with irritable bowel syndrome. Chin Med 2018;13:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6299671</ArticleId><ArticleId IdType="pubmed">30574173</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu Y, Tan Y, Qu Y, et al. A role of the subdiaphragmatic vagus nerve in depression-like phenotypes in mice after fecal microbiota transplantation from Chrna7 knock-out mice with depression-like phenotypes. Brain Behav Immun 2021;94:318&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">33422641</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>